Table 1.

Patient Characteristics.

Number	32
Follow-up period (months)	53±35	LVDd (mm)	46±5
Age (years)	65±13	LAD (mm)	34±6
Male : female	224:108	LVEF (%)	69±10
Hypertension	142 (43%)	RAAS inhibitors	80 (24%)
Diabetes Mellitus	42 (13%)	Statins	45 (14%)
Dyslipidemia	44 (13%)	Antithrombotic therapy ;
Smoking habits	89 (27%)	None	223 (67%)
Alcohol habits	134 (40%)	Aspirin	109 (33%)
Hyperuricemia	19 (6%)	ANP during SNR (pg/mL)	38±37
Underlying heart disease	65 (20%)	Onset of AF
Underlying pulmonary disease	18 (5%)	diurnal : nocturnal : mixed	65:129:138
AF history (months)	18±32